检索
AI 对话
AI 辅写
analysis
趋势分析
编组
数据平台
more
更多
排名必读论文期刊顶会热点AI 简史溯源树小脉星探人才迁徙塔尖人才国防情报追踪开源工具智慧手语
VIPCreated with Sketch.

Supplementary Table S1 from Phase I, Dose-Escalation, Two-Part Trial of the PARP Inhibitor Talazoparib in Patients with Advanced Germline <i>BRCA1/2</i> Mutations and Selected Sporadic Cancers

Johann de Bono,Ramesh K. Ramanathan,Lida Mina,Rashmi Chugh,John Glaspy,Saeed Rafii,Stan Kaye,Jasgit Sachdev,John Heymach,David C. Smith,Joshua W. Henshaw,Ashleigh Herriott,Miranda Patterson,Nicola J. Curtin,Lauren Averett Byers,Zev A. Wainberg

crossref（2023）

引用 0|浏览36
暂无评分
摘要

Supplementary Table S1. Dose-response and exposure-response parameters.

更多
查看译文
AI 理解论文
溯源树
样例
生成溯源树，研究论文发展脉络
Chat Paper
正在生成论文摘要